Global TQB2450 Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

According to our (Global Info Research) latest study, the global TQB2450 market size was valued at US$ 85.40 million in 2025 and is forecast to a readjusted size of US$ 322 million by 2032 with a CAGR of 12.7% during review period.
TQB2450 (Bemotuzumab Injection) Is A Independently Developed Programmed Death-Ligand 1 (PD-L1) Monoclonal Antibody By Chia Tai Tianqing Pharmaceutical Group, Belonging To A Novel Immune Checkpoint Inhibitor. It Specifically Blocks The PD-1/PD-L1 Signaling Pathway, Relieves The Immune Suppression Of Tumor Cells, Activates The Body’s Anti-Tumor Immune Response, And Inhibits Tumor Proliferation And Metastasis. At Present, It Has Been Developed For Multiple Solid Tumor Indications Such As Non-Small Cell Lung Cancer, Small Cell Lung Cancer And Liver Cancer, Providing A New Immunotherapy Option For Patients With Advanced Malignant Tumors.In 2025, global TQB2450 production reached approximately 45,000–50,000 vials.
TQB2450 (Bemotuzumab), a Self-Developed PD-L1 Inhibitor By Chia Tai Tianqing, Has Established Unique Competitive Advantages In The Domestic PD-(L)1 Market Through The Differentiated Combination Strategy Of "Immunotherapy Plus Anti-Angiogenesis". With A Comprehensive Layout Of Solid Tumor Indications, The Product Covers Multiple Common And Rare Tumor Types Such As Lung Cancer, Endometrial Cancer And Sarcoma. It Delivers Significant Clinical Benefits And Controllable Safety Profile Via Highly Synergistic Combination Regimens. With The Continuous Release Of Clinical Demand And Expanding Indications, Its Market Penetration Capacity Is Growing Steadily. Supported By Localized Production, Stable Supply Chain And Convenient Medication Administration, It Further Consolidates Its Core Position In The Domestic Market. Amid The Intense Global Competition Of Immunotherapy, TQB2450 Features Innovative Combination Regimens And Continuous Clinical Breakthroughs, Making It A Benchmark Product With Strong Growth Potential In The Domestic PD-L1 Sector. It Provides Diversified Treatment Options For Patients And Promotes The Development Of Domestic Tumor Immunotherapy.
This report is a detailed and comprehensive analysis for global TQB2450 market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global TQB2450 market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global TQB2450 market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global TQB2450 market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global TQB2450 market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for TQB2450
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global TQB2450 market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chia Tai Tianqing Pharmaceutical Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
TQB2450 market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
100 mg (10 mL)/vial
600 mg (20 mL)/vial
Market segment by Combination Therapy
Bemotuzumab + Anlotinib
Bemotuzumab + Paclitaxel
Market segment by Sales Channel
Hospital
Retail
Online
Market segment by Application
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Advanced Solid Tumors
Others
Major players covered
Chia Tai Tianqing Pharmaceutical Group
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe TQB2450 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of TQB2450, with price, sales quantity, revenue, and global market share of TQB2450 from 2021 to 2026.
Chapter 3, the TQB2450 competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the TQB2450 breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and TQB2450 market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of TQB2450.
Chapter 14 and 15, to describe TQB2450 sales channel, distributors, customers, research findings and conclusion.